GENMAB AS SP.ADR/1/10DK 1 (GE91) — Cash Flow Quality Index
GENMAB AS SP.ADR/1/10DK 1 (GE91) has a Cash Flow Quality Index of 1.54x as of December 2025. Operating cash flow of €301.00 Million exceeds net income of €195.81 Million, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of GENMAB AS SP.ADR/1/10DK 1 to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
GENMAB AS SP.ADR/1/10DK 1 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for GENMAB AS SP.ADR/1/10DK 1 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check GE91 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for GENMAB AS SP.ADR/1/10DK 1 (2021–2025)
Year-by-year earnings quality comparison for GENMAB AS SP.ADR/1/10DK 1. For live market cap and the full company financial profile, see GE91 stock market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.23x | €1.19 Billion | €963.00 Million | ▲ +791.0% |
| 2024 | 0.14x | €1.08 Billion | €7.84 Billion | ▼ -45.1% |
| 2023 | 0.25x | €1.10 Billion | €4.35 Billion | ▲ +146.9% |
| 2022 | 0.10x | €563.05 Million | €5.52 Billion | ▼ -86.5% |
| 2021 | 0.75x | €339.18 Million | €450.16 Million | — |